These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 3861080)

  • 21. [Pharmacokinetic studies on cefmenoxime. Distribution into the uterus and intrapelvic genital organs].
    Shindo K; Tsuburaya T; Atsumi Y; Sato M
    Jpn J Antibiot; 1986 Sep; 39(9):2386-93. PubMed ID: 3467081
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Clinical study of cefmenoxime in acute peritonitis: clinical effect and tissue concentration of cefmenoxime].
    Hashimoto I; Sawada Y; Nakamura T; Mikami J; Bekki E; Abe H; Nakanishi M; Kasai Y
    Jpn J Antibiot; 1983 Jun; 36(6):1544-52. PubMed ID: 6317906
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Clinical effect of cefmenoxime on cholecystitis; its clinical efficacy and tissue concentration].
    Bekki E; Abe H; Sawada Y; Hashimoto I; Nakamura T; Mikami J; Kasai Y; Nakanishi M
    Jpn J Antibiot; 1983 Jul; 36(7):1604-14. PubMed ID: 6317907
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Transfer of cefmenoxime to burn blister fluids].
    Nishizaki A; Aoyama H; Koh T; Izawa Y
    Jpn J Antibiot; 1984 Mar; 37(3):295-302. PubMed ID: 6330396
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Pharmacokinetics of cefmenoxime in renal-failure patients undergoing continuous arteriovenous hemofiltration].
    Hasegawa H; Itagaki N; Tsujino M; Takahashi K; Yamamoto Y; Imada A; Horiuchi A
    Jpn J Antibiot; 1988 Mar; 41(3):338-41. PubMed ID: 3165473
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Basic studies of cefmenoxime].
    Aoyama T
    Jpn J Antibiot; 1984 Mar; 37(3):290-4. PubMed ID: 6330395
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Clinical study on the tissue distribution of cefmenoxime in the field of otolaryngology].
    Fujita K; Yokoyama M
    Jpn J Antibiot; 1986 Mar; 39(3):721-5. PubMed ID: 3461174
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intraocular penetration of cefmenoxime (SCE-1365), A new cephalosporin, in humans.
    Takahashi N; Takahashi K; Takagi M
    Nippon Ganka Gakkai Zasshi; 1982; 86(4):337-40. PubMed ID: 6287821
    [No Abstract]   [Full Text] [Related]  

  • 29. [Antibiotic concentrations in the area of the vitreous body following vitrectomy and vitrectomy and lensectomy].
    Völker B; Mester U; Berkemeier A
    Fortschr Ophthalmol; 1984; 81(3):260-2. PubMed ID: 6090282
    [No Abstract]   [Full Text] [Related]  

  • 30. [A study on the penetration of cefmenoxime into bile and gallbladder tissues and the pathological changes of inflamed tissues].
    Tsuburaya H; Ando Y; Kimizima I; Watanabe I; Abe R; Funayama T; Kawaguchi Y
    Jpn J Antibiot; 1986 Sep; 39(9):2381-5. PubMed ID: 3467080
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Clinical evaluation of cefmenoxime and cefsulodin in chronic complicated urinary tract infections].
    Shiraiwa Y; Yamaguchi O; Ito K; Kuma Y; Hozumi S; Kumakawa K; Ishiwata H; Arai M; Hirai T; Kumagai I
    Jpn J Antibiot; 1986 Oct; 39(10):2661-74. PubMed ID: 3468273
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Penetration of cefmenoxime into serum, gynecologic tissues, and heart valves.
    Daschner FD; Petersen EE; Frank U; Hornig D
    Am J Med; 1984 Dec; 77(6A):4-6. PubMed ID: 6097123
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Effective intraocular cefmenoxime levels following subconjunctival injection: studies of the penetration of cefmenoxime into the aqueous humor of the human eye].
    Duncker G; Manthey KF; Ullmann U
    Fortschr Ophthalmol; 1986; 83(3):332-4. PubMed ID: 3462114
    [No Abstract]   [Full Text] [Related]  

  • 34. [Studies on the intravenous administration of cefmenoxime in pediatric field].
    Nakazawa S; Sato H; Niino K; Hirama Y; Narita A; Nakazawa S; Chikaoka H; Oka S
    Jpn J Antibiot; 1982 Oct; 35(10):2393-404. PubMed ID: 6306291
    [No Abstract]   [Full Text] [Related]  

  • 35. [Concentration of intravenously infused cefotiam dihydrochloride in human vitreous cavity].
    Kamiya I; Akikusa M; Kohzuka T
    Nippon Ganka Gakkai Zasshi; 1983; 87(11):1106-11. PubMed ID: 6322549
    [No Abstract]   [Full Text] [Related]  

  • 36. [Intravitreous penetration of cefotaxime in man].
    Bonissent JF; Colin J; Riche C
    J Fr Ophtalmol; 1984; 7(12):823-4. PubMed ID: 6100114
    [No Abstract]   [Full Text] [Related]  

  • 37. Study of the diffusion of cefmenoxime into the bronchial secretions.
    Serieys C; Bergogne-Berezin E; Kafe H; Bryskier A
    Chemotherapy; 1986; 32(1):1-6. PubMed ID: 3456295
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Optimal conditions for injection of tobramycin and cefmenoxime into burn patients.
    Aoyama H; Izawa Y; Nishizaki A; Okuda J
    Burns Incl Therm Inj; 1987 Aug; 13(4):269-76. PubMed ID: 3478113
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Clinical evaluation of cefmenoxime (CMX) for complicated urinary tract infection].
    Tsuchida S; Sasaki S; Takada H; Miyagata S; Sato S; Shimizu S; Sakamoto F; Kizu N
    Hinyokika Kiyo; 1985 Feb; 31(2):365-74. PubMed ID: 3859998
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacokinetics of SCE-1141, a stereoisomer of cefmenoxime, in rats.
    Kita Y; Itakura K; Tsuchiya K; Imada A
    J Antimicrob Chemother; 1986 Feb; 17(2):205-13. PubMed ID: 3457784
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.